BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25229938)

  • 1. Resistance to therapy in acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; de Thé H
    N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
    Zhang X; Pan J
    Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895
    [No Abstract]   [Full Text] [Related]  

  • 3. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
    Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
    Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
    Vitoux D; Nasr R; de The H
    Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.
    Ng Liet Hing M; Ryland GL; Nguyen T; Tiong IS; Dun K; Ninkovic S; Nedumannil R; Westerman DA; Blombery PA; Chan KL; Bajel A
    Br J Haematol; 2023 Aug; 202(4):893-896. PubMed ID: 37280781
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy-free treatment of acute promyelocytic leukemia.
    Ravandi F
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):498-500. PubMed ID: 26351810
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia.
    Young CS; Clarke KM; Mills KI
    EBioMedicine; 2015 Jun; 2(6):487-8. PubMed ID: 26288810
    [No Abstract]   [Full Text] [Related]  

  • 8. APL, a model disease for cancer therapies?
    de Thé H; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
    [No Abstract]   [Full Text] [Related]  

  • 9. Hot on the TRAIL of acute promyelocytic leukemia.
    Zelent A
    Nat Med; 2001 Jun; 7(6):662-4. PubMed ID: 11385499
    [No Abstract]   [Full Text] [Related]  

  • 10. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
    Komatsu N
    Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute promyelocytic leukemia.
    Miura Y; Suyama K; Takano T
    N Engl J Med; 2013 Oct; 369(15):1471-2. PubMed ID: 24106949
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute promyelocytic leukemia.
    Lo-Coco F; Orlando SM; Platzbecker U
    N Engl J Med; 2013 Oct; 369(15):1472. PubMed ID: 24106948
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to arsenic therapy in acute promyelocytic leukemia.
    Zhu HH; Qin YZ; Huang XJ
    N Engl J Med; 2014 May; 370(19):1864-6. PubMed ID: 24806185
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting agents alone to cure acute promyelocytic leukemia.
    Chen SJ; Chen Z
    N Engl J Med; 2013 Jul; 369(2):186-7. PubMed ID: 23841735
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
    Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
    Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?
    Ravandi F; Kantarjian H
    Lancet Oncol; 2015 Oct; 16(13):1274-5. PubMed ID: 26384240
    [No Abstract]   [Full Text] [Related]  

  • 18. How health-related quality-of-life outcomes in patients with acute promyelocytic leukemia can help physicians in decision making.
    Koehler M; Fischer T
    J Clin Oncol; 2015 Mar; 33(9):1090-1. PubMed ID: 25691667
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
    Ma J
    Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
    George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
    Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.